CLINICAL_TRIALS
trial_result
· 2014-02-21
Clinical Trial Update: Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia [Phase 2]
Summary
A Phase 2 trial evaluated the efficacy and safety of DWP05195 in subjects with postherpetic neuralgia, and the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED